Your champion loves the page you wrote. She's read it twice, sent it to herself on Slack, and now she has to get it in front of the VP who signs off on new software. So she opens a new message, pastes the link, and starts typing her own summary above it.
That's the moment most content strategy ignores. The piece did its job on her. It hasn't done anything yet for the person she's about to send it to.
The handoff nobody writes for
Content strategy in health tech almost always gets built for the reader who finds the page cold: the right keyword, the right search intent, the right hook in the first two lines. All of that matters. None of it survives the moment your champion has to hand the page to someone who's never heard of you.
That handoff happens dozens of times inside a single deal. A marketing manager forwards a case study to her CEO. A clinical director pastes a link into a group chat with two practice partners. An office manager prints a page and puts it on the desk of the owner who actually signs.
Each time, your champion becomes the translator. She has to explain why this matters, in her own words, to someone who wasn't in the room for the demo and hasn't spent 20 minutes on your site.
Most content makes her do that work alone. The good stuff does it for her.
What forwarding actually requires
A page that reads well and a page that forwards well are not the same test. Reading well means someone finishes it. Forwarding well means someone else, three steps removed from your sales process, can open it cold and get the point in under a minute.
Four things separate the two.
A headline that carries the argument. A topic label like "Patient communication trends in 2026" tells a forwarded reader nothing. "Why practices are dropping their SMS vendor within a year of signing" tells them exactly what they're about to read and why someone thought they should read it.
A first paragraph that works with zero context. The person opening a forwarded link doesn't know your product, your champion's role, or why this landed in their inbox. If the opening line assumes any of that, you've lost them before the second paragraph.
A claim that survives being repeated secondhand. Your champion is going to summarize your argument in one sentence to her boss. If that sentence isn't already sitting somewhere in your piece, ready to be lifted, she'll invent her own version, and it will be weaker than yours.
Nothing that requires you in the room to make sense. If a stat, a comparison, or a claim only lands because your champion can add verbal context, it won't survive the forward. Write it so it stands on its own.
What it looks like inside a real deal
A practice management vendor's marketing manager gets a warm reply from a dental group's office manager after three months of publishing. The office manager likes what she's read. She's not the buyer, though, and she reports to a managing partner who's never visited the website and never will.
So she does what champions do. She opens the vendor's best article on patient no-show rates, skims it again to make sure it still holds up, and forwards it with one line: "This is the company I mentioned. Worth a look before Thursday."
The managing partner opens it on his phone between patients. He has 45 seconds, no memory of the earlier conversation, and zero interest in reading a 2,000 word article cold. He reads the headline, the first two lines, and maybe one subheading before deciding whether Thursday's meeting is worth keeping.
Everything that matters in those 45 seconds got decided weeks earlier, when the article was written, by whoever drafted the headline and the opening paragraph. Nobody in that room, not the sales rep and not the office manager, gets a say at the moment it counts.
Why this matters more in health tech than almost anywhere else
A four to six person buying group is normal for a mid-market health practice tech deal. The champion who found you rarely has sign-off authority on her own.
She's convincing an office manager, a clinical lead, a partner group, sometimes all three, and she's doing it without you present for most of those conversations. Every one of them either gets easier or harder based on whether the content she's forwarding does the convincing for her.
Compare that to a low-complexity purchase. A single decision-maker reads your page and buys. There's no handoff, no translation, no forwarding.
Complex sales in clinical markets don't work that way. Content built for the single-reader model quietly fails every time it hits an internal audience it wasn't written for.
What this gives Sarah to show her VP
If you're the one running content for a health practice tech company, you already get asked to prove the channel works. Traffic and rankings satisfy that question for about a quarter. After that, someone wants to know what the content is actually doing for pipeline.
Forward-readiness is a lever you can point to directly. Ask your sales team which pages get pasted into their own follow-up emails without edits. Ask which ones a prospect mentions unprompted on a second call, the ones that clearly got shared inside the buying group before you were ever looped in.
That's a harder number to fake than sessions or bounce rate, and it's a much easier one to defend in a leadership meeting. "This page got forwarded past three people inside a deal that closed" lands better than any traffic chart. It ties the work directly to the thing your VP actually cares about.
The tell that you've gotten this wrong
You won't see this failure in your traffic numbers. Sessions look fine. Time on page looks fine. The page is doing exactly what it was built to do for the person who found it.
The failure shows up two steps later, in a stalled deal you can't quite explain. Your champion goes quiet for a week, then comes back and says the partners "need to think about it."
Nobody tells you the real reason. She tried to forward your best page to the group, got three follow-up questions she couldn't answer, and gave up halfway through the conversation.
That stall gets logged as a "no decision" in your CRM. It was actually a content failure, four steps removed from where you'd ever go looking for one.
A test before you publish
Before a piece goes live, do this. Copy the headline and the first two sentences into a blank message, with no other context, and read them as if you're a partner in a dental group who's never heard of your company.
Ask whether those two sentences alone tell you why you're reading this and why it's worth your next 90 seconds. If the answer is no, the piece isn't ready.
The writing itself might be fine. It was just built for the reader who arrives with context, and that's rarely the reader who decides whether the deal moves forward.
Two quick checks catch most of the problems.
Read only the bolded and header text, top to bottom. Skip every paragraph in between. If that skeleton alone doesn't carry the argument, a rushed partner skimming on a phone will miss it too.
Find the sentence that would survive being quoted alone in a group chat. If nothing in the piece works as a standalone quote, your champion will have to write that sentence herself, and you've handed her homework instead of ammunition.
What this changes about the brief
A good content brief for a complex sale should name the forward path before a single word gets written. Who finds this piece first. Who they're likely to send it to next.
What that second reader needs in the first ten seconds. Whether a third reader ever gets pulled in after that.
That's a different question than "what keyword is this targeting" or "what funnel stage is this for." Both of those questions assume one reader, and health tech deals almost never have one reader.
Write the headline for the forward. Write the opening for the reader who wasn't there. Put the argument in a sentence your champion could lift word for word into a Slack message at 11pm the night before a partner meeting.
Do that consistently, and you shorten every internal conversation happening without you in the room. That's the whole point of content in a sales cycle this long: doing work when you can't be there to do it yourself.
The metric worth adding
Most content reporting stops at traffic and demo requests. Neither tells you whether a piece survived being forwarded three times inside a buying committee before anyone signed anything.
You can't measure that directly, but you can ask for it. On your next client or prospect call, ask what got forwarded internally and what didn't.
The answer will tell you more about which pieces are actually shortening your sales cycle than six months of analytics ever will.